Monteggia LM. A neurotrophic model for stress-related mood disorders.
Biol Psychiatry 2006;59:1116–1127.
Conley RR et al. Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects.
Arch Gen Psychiatry 2003;60:804–815.
Okamura N et al. Alterations of serum levels of brain derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants.
Biol Psychiatry 2003;54:70–75.
Gervasoni N et al. Low brain-derived neurotrophic factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity.
Biol Psychiatry 2005;57:1068–1072.
Bondolfi G et al. Decreased serum brain-derived neurotrophic factor levels in major depressed patients.
Psychiatry Res 2002;109:143–148.
Callicott JH et al. The BDNF val66met polymorphism affects activity dependent secretion of BDNF and human memory and hippocampal function.
Cantor RM et al. The brain-derived neurotrophic factor rs6265 (Val66Met) polymorphism and depression in Mexican-Americans.
Yu YW et al. Association study of a brain-derived neurotrophic-factor genetic polymorphism and major depressive disorders, symptomatology, and antidepressant response.
Am J Med Genet B Neuropsychiatr Genet 2003;123:19–22.
Yen FC et al. Association study of a brain-derived neurotrophic-factor genetic polymorphism and mood disorders, age of onset and suicidal behavior.
Becker T et al. Evidence for a relationship between genetic variants at the brainderived neurotrophic factor (BDNF) locus and major depression.
Biol Psychiatry 2005;58:307–314.
11.American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th edn. Washington, DC: American Psychiatric Press, 1994.
12.Hamilton M. A rating scale for depression.
J Neurol Neurosurg Psychiatry 1960;23:56–62.
13.Hamilton M. The assessment of anxiety states by rating.
Br J Med Psychol 1959;32:50–55.
Liu YL. Serum brain-derived neurotrophic factor levels in patients with major depression: effects of antidepressants.
J Psychiatr Res 2008;42:521–525.
Catena M et al. Plasma and serum brain-derived neurotrophic factor (BDNF) in depressed patients during 1 year of antidepressant treatments.
J Affect Disord 2008;105:279–283.
Bondolfi G et al. Partial normalization of serum brain-derived neurotrophic factor in remitted patients after a major depressive episode.
Shi YM et al. The decreased serum BDNF concentrations of amnestic mild cognitive impairment is unrelated to the Val66Met polymorphism in Chinese Han.
J Clin Psychiatry 2008;69:1104–1111.
Fasold MB et al. Transport of brain-derived neurotrophic factor across the blood-brain barrier.
Kim YK. Plasma brain-derived neurotrophic factor as a peripheral marker for the action mechanism of antidepressants.
Martti H et al. Brain-derived neurotrophic factor (BDNF) polymorphisms G196A and C270T are not associated with response to electroconvulsive therapy in major depressive disorder.
Eur Arch Psychiatry Clin Neurosci 2007;257:31–35.
Iyo M. Ethnic difference of the BDNF 196G/A (val66met) polymorphism frequencies: the possibility to explain ethnic mental traits.
Am J Med Genet B Neuropsychiatr Genet 2004;126B:122–123.
Hong CJ et al. The Val66Met polymorphism of the brain-derived neurotrophic-factor gene is associated with geriatric depression.
Neurobiol Aging 2006;27:1834–1837.
Mentschel C et al. Brain-derived neurotrophic factor Val66met polymorphism and volume of the hippocampal formation.
Mol Psychiatry 2005;10:631–636.
Ward PB et al. Reduced hippocampal volumes and memory loss in patients with early and late-onset depression.
Br J Psychiatry 2005;186:197–202.
Koizumi H et al. No association of the brain-derived neurotrophic factor (BDNF) gene polymorphisms with panic disorder.
Prog Neuropsychopharmacol Biol Psychiatry 2005;29:708–712.